<h1>India Reviews Pharma Takeovers for Impact on Healthcare, Pricing; Considers Compulsory Licenses Under Patent Act 1970.</h1> Following recent takeovers of Indian pharmaceutical companies by multinational corporations, concerns have arisen about potential impacts on healthcare, drug pricing, and availability in India. The Department of Pharmaceuticals has requested a study from the Department of Commerce on these acquisitions. Recommendations from this study will be submitted to the Economic Advisory Council to the Prime Minister. While multinational representatives, including those from US drug companies, seek to protect their interests in India, the government aims to safeguard patient interests. Compulsory licenses may be issued under the Indian Patent Act, 1970, as amended in 2005, to address these concerns.